Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 7,500 full-time employees. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. The company also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
最新の財務諸表(Form-10K)によると、Merit Medical Systems Incの総資産は$2,685で、純利益は$128です。
MMSIの主要な財務比率は何ですか?
Merit Medical Systems Incの流動比率は2.43、純利益率は8.44、1株当たり売上高は$25.05です。
Merit Medical Systems Incの収益はセグメントまたは地域別にどのように分けられていますか?
Merit Medical Systems Inc の最大収益セグメントは Cardiovascular で、最新の利益発表における収益は 700,613,000 です。地域別に見ると、United States が Merit Medical Systems Inc の主要市場であり、収益は 800,780,000 です。
Merit Medical Systems Incは収益を上げていますか?
はい、最新の財務諸表によると、Merit Medical Systems Incの純利益は$128です。